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Abstract:  Japan  is  currently  experiencing  the  most  rapid  population  aging  among  all 
OECD countries. Increasing expenditures on medical care in Japan have been attributed to 
the aging of the population. Authors in the recent debate on end-of-life care and long-term 
care  (LTC)  cost  in  the  United  States  and  Europe  have  attributed  time  to  death  and  
non-medical care cost for the aged as a source of rising expenditures. In this study, we 
analyzed a large sample of local public insurance claim data to investigate medical and 
LTC expenditures in Japan. We examined the impact of aging, time to death, survivorship, 
and use of LTC on medical care expenditure for people aged 65 and above. On the basis of 
these findings, we conclude that age is a contributing factor to the rising expenditures on 
LTC, and that the contribution of aging to rising medical care expenditures should be 
distinguished according to survivorship. 
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1. Introduction  
1.1. Population Aging and End-of-Life Medical Care Costs 
Rising expenditures on formal services associated with medical and long-term care (LTC) in aging 
societies has led researchers and policy makers to examine the use of medical services prior to death. 
An  early  study  of  Medicare  data  in  the  United  States  by  Lubitz  and  Prihoda [1]  estimated  that  
end-of-life medical expenditures accounted for 28% of the total annual medical expenditures in the 
country. According to their results, the majority of this amount was spent within one month before 
death. Other studies using updated Medicare data [2,3] have consistently reported that, in spite of the 
recent  introduction  of  alternative  services  such  as  hospice  and  homecare,  the  share  of  end-of-life 
medical expenditures has remained almost constant over time. Barnato, et al. [4] attributed the increase 
in medical expenditures to an increase in the intensity of treatment under inpatient care offsetting the 
decrease in in-hospital deaths.  
In Japan, rising expenditures on medical and LTC services have evoked a serious policy debate, 
wherein the aging of the population is widely considered to be the major driving force behind these 
increasing costs. Of all OECD countries, Japan has experienced the most rapid rate of population aging 
in  the  recent  period.  In  2008,  the  proportion  of  the  population  aged  65  and  over  
had  already  reached  22%  of  the  total  population.  As  such,  it  is  imperative  that  policy  makers  in  
Japan  understand  precisely  how,  and  to  what  extent,  population  aging  influences  expenditures  on 
medical care and LTC. 
Ogura, et al. [5] produced the first estimate of end-of-life medical expenditures in Japan, using 
claim bill data collected from local public health insurers in the late 1980s. They estimated that the 
share of end-of-life medical expenditure for people aged 70 and over was 19.2% of annual medical 
expenditures. Fukawa [6] conducted a similar analysis using claim data collected from 12 prefectures 
in the early 1990s for beneficiaries aged 70 and over. It was found that the proportion of end-of-life 
medical care (inpatient and outpatient services) was 12% of the total annual expenditure, and that the 
majority of this amount was spent within the three months immediately prior to death. This increase in 
expenditures before death was attributed to two factors: an increase in the probability of admission and 
an increase in cost per case. A study by Konno [7] examined Employee Health Insurance claim bill 
data from the late 1990s, and estimated that the proportion of end-of-life expenditure was 22.4% of the 
total expenditure for those aged 65 and over. In addition, this study also reported that the medical 
expenditures  of  decedents  compared  to  the  medical expenditure  of  survivors  was  about  5.3  times 
greater for those aged 70 and over. The Institute of Health Economics and Policy [8] estimated that the 
average medical expenditure one month prior to death was approximately 1,120,000 Japanese Yen 
(JPY; equivalent to $11,200 US at an exchange rate of 1 USD = 100 JPY). The Bureau of Insurance in 
the  Ministry  of  Health,  Welfare,  and  Labour  multiplied  this  number  by  the  estimated  number  of 
hospital  deaths  in  2002  (approximately  0.8  million),  arriving  at  an  estimate  of  annual  
―end-of-life expenditure in inpatient service‖ for 2002 of 900 billion JPY, or 9 billion US dollars.  Int. J. Environ. Res. Public Health 2010, 7                 
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1.2. Review of the “Red herring” Debate 
It  has  been  proposed  by  several  authors  that  the  figure  announced  by  the  Ministry  is  an  
overestimate,  because  end-of-life  medical  expenditure  declines  with  age [3,6,7,9].  The  decline  in  
end-of-life medical care expenditures among the older old is thought to be caused by a decrease in the 
probability of service use [10], or a decrease in the intensity of care [11,12]. Thus, projections of the 
growth  in  medical  expenditures  produced  by  simply  multiplying  the  current  age-specific  medical 
expenditure by an estimate of future population are likely to be overestimated compared to estimates 
based on more sophisticated models that take end-of-life expenditure into consideration [13,14]. 
In the so-called ―red herring‖ debate [15], it has been argued that time-to-death (TTD), rather than 
population aging per se, is the cause of rising medical expenditure. Subsequent studies using more 
sophisticated econometric techniques [10,16], confirmed that TTD was a significant factor, although, it 
was argued that aging is also an important contributing factor to rising medical expenditures. 
The studies discussed so far focused only on medical services, and ignored the cost of LTC. As 
such, they do not provide a complete picture of the total healthcare costs of the elderly before death. 
Hoover, et al. [17] used the 1992–1996 Medicare Current Beneficiary Survey data and found that 
although medical expenditure on end-of-life care was lower in the elderly, non-Medicare expenditure 
was higher for older beneficiaries. Further, they found that end-of-life medical expenditures increased 
sharply during the month of death whereas non-Medicare expenditure was stable over the year. They 
concluded that custodial and chronic care, which is covered by non-Medicare expenditures, should also 
be seriously considered to improve resource allocation for end-of-life care of the elderly. Using the 
claim data of dual beneficiaries for Medicare and Medicaid in 10 states, Liu, et al. [18] confirmed this 
trend in medical care and LTC expenditures before death.  
Polder, et al. [14] used a large representative sample of public insurance data from The Netherlands 
to estimate the total healthcare costs, including the cost of medical care and LTC. They confirmed that 
the cost of medical care decreased with age for decedents, whereas the cost of LTC increased with age. 
In addition, they found that elderly survivors spent less on medical care compared to decedents, but 
their medical cost did not vary across age groups. Furthermore, since LTC among elderly survivors 
increased with age, the healthcare cost of survivors aged 80 and over was about half of the total 
healthcare  cost  of  decedents.  Thus,  they  concluded  that  aging  per  se  could  not  be  ignored  as  a 
contributing cause of rising healthcare expenditures. 
On the basis of Swiss claim data, Werblow, et al. [19] proposed that the impact of TTD and age on 
end-of-life healthcare cost differs according to survivorship and use of  LTC. Although the annual 
medical  expenditure  for  decedents  who  did  not  use  LTC  was  extremely  high,  this  expenditure 
decreased with age. In contrast, for survivors without LTC this expenditure increased with age until the 
age of 85, but decreased thereafter. For decedents and survivors who used LTC, expenditure was lower 
as  compared  to  the  expenditure  of  long-term  non-users,  but  increased  monotonously  with  age. 
However, the Swiss claim data used in this previous study was limited to the medical component  
of LTC, and did not include the cost of custodial care at home or the accommodation cost incurred  
at nursing homes.  
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1.3. Purpose of the Study 
A review of the current literature raises a number of unanswered questions. For example, the impact 
of further aging of the population on medical and LTC expenditure is currently unclear. Similarly, it is 
unclear  how  the  use  of  formal  LTC,  including  homecare  and  institutional  care,  affects  medical 
expenditures on the elderly. Since East Asian countries are currently facing the most rapid increase in 
population aging in the World, any study seeking to answer these questions for Japan will also be 
relevant for other countries in this region.  
Data from Japan are unique and appropriate for conducting such an analysis for several reasons. 
First,  Japanese  public  medical  insurance  provides  a  comprehensive  coverage  for  outpatient  and 
inpatient medical services that cover the cost of physicians, hospitals, drugs, laboratory examinations, 
dental care, and surgical equipment. Medical insurance does not cover services that are regarded as 
less essential, e.g., health check-ups, eyeglasses, and over-the-counter pharmaceuticals. Japanese LTC 
insurance provides coverage for formal services to provide custodial care at home by professional 
helpers, respite services, outpatient rehabilitation service, visiting nurse services, and institutional care 
at nursing homes. Care at nursing homes does not include medical care, except for limited items, and 
mainly comprises custodial care. At the time of data collection, meal and accommodation expenses at 
nursing homes were also covered under institutional care. Unlike the system in Germany, Japanese 
LTC insurance does not cover cash benefits to informal caregivers.  
Although private insurance providers exist in Japan, the current law permits them to cover only a 
limited proportion of out-of-pocket payments. With the national fee schedule and the fee-for-service 
basis of reimbursement from medical and LTC insurance, it would thus be expected that claim data for 
public insurance would provide a precise and comprehensive picture of the expenditure incurred by 
providing  formal  medical  and  LTC  services  to  the  elderly.  Importantly,  this  would  be  the  first  
detailed  analysis  of  total  healthcare  cost  for  the  elderly  in  a  non-European  setting  based  on  such  
a large database. 
In the current study, we estimated the total health cost of end-of-life care for the elderly in Japan, 
and compared the expenditure pattern over the course of TTD across service types. In the following 
analysis,  we divided  medical  service  into outpatient  and  inpatient  services,  and  divided  LTC  into  
non-institutionalized care (or homecare) including respite services, and institutional care at nursing 
homes. In addition, we also compared the annual expenditures on decedents and elderly survivors, and 
studied how the survivorship, use of LTC, and age affected expenditure for each type of service. On 
the basis of these findings, we propose that age is a contributing factor in the rising expenditures on 
medical care and LTC, and that LTC is not a cheaper substitute for medical care.  
2. Methods 
2.1. Data Sources 
Claim  data  was  obtained  from  a  public  authority  in  a  prefecture  in  the  Kyushu  district  in  the 
southern part of Japan. The data covered claim data for medical care and LTC by National Health 
Insurance for beneficiaries aged 65 and over in the prefecture from 2000 to 2004. In Japan, National 
Health Insurance is a public insurance offered by municipalities, and covers self-employed and retired Int. J. Environ. Res. Public Health 2010, 7                 
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persons. Employees of large companies are covered by the Employee Health Insurance, and are not 
included in this dataset. Medical insurance covers hospital fees, physician fees, and prescription fees. 
In this study, we excluded fees associated with dental services from the analysis. 
The data included a unique identifier, the age and sex of each beneficiary, the type of service used, 
the month during which the service was used, monthly expenditures on the use of the service, and exit 
information (death or move-out). Using the unique identifier and month, we prepared panel data that 
served as the master database. From this master database, we prepared two sub-datasets for analysis. 
The first dataset was used for the analysis of decedents. For this purpose, we first identified people 
who had died in 2001, 2002, or 2003, then prepared their claim data over the 12 months prior to the 
month of the death. This dataset included 50,857 decedents.  
The  second  dataset  was  used  for  conducting  a  comparative  analysis  between  decedents  and 
survivors. We identified people who were alive in March 2004, and collected their annual expenditure 
by type of service used during April 2002 to March 2003. Thus, as reflected in the claim data, these 
elderly  people  had  survived  for  at  least  12  months  after  they  had  used  the  service.  This  dataset 
included 364,484 survivors. 
For brevity, the sample population was categorized into three age groups: 65–74, 75–84, and 85 
plus. Medical care was subcategorized into outpatient and inpatient care. Prescription and drug fees 
were included either in outpatient or inpatient fees, depending on where the prescription was issued. In 
Japan, until the 1980s, drugs were sold by clinics or hospitals through prescription. The government 
then  introduced  a  policy  to  promote  divisionalized  drug  sale  at  pharmacies  and  to  prevent  
over-prescription by clinics. However, in rural areas with few pharmacies, some clinics continue to sell 
drugs. Therefore, in this study, we combined prescription and drug fees with medical care fees. LTC 
was subcategorized into home care (including respite care) and institutional care at nursing homes as 
previously described.  
2.2. Analysis 
We  followed  the  two-part  model  by  estimating:  (1) the  probability  of  service  use,  and  (2) the 
amount of expenditure that was conditional on the use of the service. We adopted a strategy similar to 
that  of  Polder,  et  al. [14],  and  relied  on  descriptive  analysis  instead  of  econometric  modeling 
techniques. We chose to do so because the available dataset contained limited information on the 
beneficiaries,  such  as  age  and  sex,  so  the  explanatory  power  of  any  regression  model  would  be 
expected to be weak. In addition, simple descriptive statistics on service use are easier to comprehend.  
For conducting the analysis of the decedents, we calculated the probability of service use and the 
amount of monthly expenditure conditional on service use by age category and month-to-death. The 
results were plotted on a graph to show trends in probability of use and monthly expenditure over the 
12 months prior to death. The monthly probability of service use for decedents (P. jt) was estimated for 
each age category using the formula below: 
                                                (1) 
where: 
Iijt = 0 if the ith patient did not use the jth service in the t months before death  Int. J. Environ. Res. Public Health 2010, 7                 
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Iijt = 1 if the ith patient used the jth service in t months before death 
  t = 0 ~ 11 months to death 
  j = 1 ~ 4 (1 = outpatient, 2 = inpatient, 3 = homecare and 4 = institutional care) 
  Nd = total number of decedents in the age category 
Monthly expenditure conditional on service use for decedents (C.jt) was estimated as:  
                                                 (2) 
where Cijt = service use (in JPN) by the ith patient for the jth service in the t months before death. 
For a comparative analysis of the decedents and the survivors, we calculated the annual expenditure 
for each type of service. When calculating the probability of use, no service use in a year was set to 0. 
The estimated probability of use and the amount of service use conditional on use were plotted for 
different age categories by survivor status. A similar analysis was conducted for the use of outpatient 
services and inpatient services. This was further stratified by survivorship and use of  LTC (as in 
Werblow, et al. [19]). In a formula, the annual probability of service use (AP.jk) for decedents and 
survivors was estimated for each age category with the formula: 
                                              (3) 
where: 
AIijk =0 if the i th patient in k th status did not use the j th service during the targeted 12 months  
AIijk = 1 if the i th patient in k th status used the j th service during the targeted 12 months 
  j = 1~4 (1 = outpatient, 2 = inpatient, 3 = homecare and 4 = institutional care) 
  k = 1~2 (1 = decedent 2 = survivor) 
Nk = total number of decedents (k = 1), or of survivors (k = 2) in the age category 
Annual expenditure conditional on service use by decedents and survivors (AC.jk) was then 
estimated for each age category by: 
                                                (4) 
where ACijk = service use (in JPN) by the i  th patient with the kth status for the jth service in the  
targeted 12 months 
Finally, the average annual expenditure of service use (E(AC.jk)) for the j th service use among kth 
status patients was obtained by:  
    E(AC.jk) = AP.jk × AC.jk                                                (5) 
The estimated value was analyzed by age and survivorship categories. Since the decedents were 
drawn  from  a  three-year  period,  we  first  divided  the  total  number  of  decedents  by  3.  Next,  we 
multiplied this number by the average annual expenditure of the decedents to obtain the annual total 
health cost for decedents. This number was compared with the corresponding annual cost obtained  
for survivors.  Int. J. Environ. Res. Public Health 2010, 7                 
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3. Results 
Table 1 shows the basic characteristics of the elderly decedent and survivor beneficiaries. The data 
showed that decedents were older than the survivors. The majority of decedents (nearly 70%) died in 
hospitals.  This  number  was  lower  than  the  estimated  proportion  of  81%  for  the  whole  Japanese 
population reported by Ikegami  [20] using 2002 vital statistics. Because our sample was limited to 
elderly cases, the proportion of institutional deaths against hospitals deaths would be expected to be 
higher than Ikegami‘s estimate. We had information on the cause of death for a sub-sample of the 
decedents. The data from this sub-sample showed that 22.1% of deaths were caused by neoplasm, 
13.9% by stroke, and 12.1% by heart disease. 
Table 1. Characteristics of decedent and survivor beneficiaries aged 65 and over. 
    Decedent  %      Survivor  %     
p value 
(χ
2 test) 
Sampled year    2001–2003      Apr.2002–Mar.2003       
                    
Total number    50,857        364,484          
                                  
Age                     
65–74    8,558  (16.8)      125,941   (34.6)       
75–84    19,968  (39.3)      177,720   (48.7)       
85–     22,331  (43.9)     60,823   (16.7)     <0.001 
Gender                     
female      25,726  (50.6)      218,638   (60.0)     <0.001 
Recipients of care types                     
outpatient    40,575   (79.8)      344,051   (94.4)    <0.001 
inpatient    38,833   (76.4)      87,949   (21.1)    <0.001 
home care    16,341   (32.1)      43,345   (11.9)    <0.001 
institutional care      12,588   (24.8)      15,868   (4.4)     <0.001 
Death place                 
nursing homes    6,218  (12.2)           
hospitals    35,199  (69.2)           
other than  
nursing homes/ hospitals 
 (including at home) 
  9,440  (18.6)           
Figure 1 shows the probability of outpatient service use, and monthly expenditures among those 
who used the service, for each month until death. The probability of use was constant over time, but 
decreased during the last two months. Monthly expenditures conditional on service use were almost 
constant until the month of death. Older decedents  exhibited a lower probability of use and lower 
monthly expenditure over the period until death. It should be noted, however, that the expenditure 
during the month of death does not necessarily cover the full month (i.e., if the death occurred in the 
middle of the month). This is also true for the data shown in the following Figures 2, 3, and 4.  Int. J. Environ. Res. Public Health 2010, 7                 
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Figure 1. Outpatient service use and months to death. 
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Figure  2  shows  the  probability  of  use  and  monthly  expenditure  conditional  on  service  use  for 
inpatient services over the months to death. It can be seen that the probability of use and monthly 
expenditure increased gradually over the time period, but drastically rose in the two months prior  
to  death,  particularly  in  the  last  month  before  death.  This  trend  is  similar  to  that  reported  in  
previous studies. Again, older decedents had a lower probability of use as well as lower monthly 
expenditure over TTD. 
Figure 2. Inpatient service use and month to death. 
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Figure  3  shows  the  probability  of  use  and  monthly  expenditure  conditional  on  service  use  for 
homecare services over the months to death. Both the probability of use and monthly expenditure 
conditional  on  service  use  were  constant  over  the  months  until  death.  In  contrast  to  the  case  for 
medical services, the probability of use and the amount of monthly expenditure conditional on service 
use were highest for the oldest age category. 
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Figure 3. Homecare use and months to death. 
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Figure  4  shows  the  probability  of  use  and  monthly  expenditure  conditional  on  service  use  for 
institutional  services  over  the  months  to  death.  The  probability  of  use  and  monthly  expenditure 
conditional on service use were both constant over months until death. This trend is similar to the trend 
observed for homecare services. However, monthly expenditure conditional on service use did not 
differ  across  age  categories.  This  is  an  important  finding  with  respect  to  institutional  care.  Since 
institutional costs comprise custodial care and accommodation, they should be dependent only on the 
level of functioning and not on age. 
Figure 4. Institutional care service use and months to death. 
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Figure 5 shows the annual use of outpatient care services by decedents and survivors. We found that 
the probability of use decreased with age, and that it was consistently higher for survivors than for 
decedents. The amount of monthly expenditure conditional on  service use decreased with age for 
decedents, though, for survivors, a decline with age was not apparent.  Int. J. Environ. Res. Public Health 2010, 7                 
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Figure 5. Outpatient service use by survivorship and age. 
0
0. 1
0. 2
0. 3
0. 4
0. 5
0. 6
0. 7
0. 8
0. 9
1
0
100
200
300
400
500
600
700
800
65-74 75-84 85-
U
s
e
 
P
r
o
b
a
b
i
l
i
t
y
E
x
p
e
n
d
i
t
u
r
e
 
(
1
,
0
0
0
 
J
P
Y
/
y
e
a
r
)
Age
Fi gure  5.  O utpati ent Servi ce Use  by Survi vorshi p and Age
Expendi ture 
per  user 
decedent
Expendi ture 
per  user 
survi vor
Use  probabi l i ty 
decedent
Use  probabi l i ty 
survi vor
 
Figure  6  shows  the  annual  use  of  inpatient  care  services  by  decedents  and  survivors.  Two 
observations in these results are particularly notable. First, the probability of use and the monthly 
expenditure conditional on service use were both higher for decedents compared to survivors. Second, 
both the probability of use and monthly expenditure conditional on service use decreased in the older 
age categories for decedents, but increased with age in the case of elderly survivors. 
Figure 6. Inpatient service use by survivorship and age. 
0
0. 1
0. 2
0. 3
0. 4
0. 5
0. 6
0. 7
0. 8
0. 9
1
0
500
1000
1500
2000
2500
3000
3500
65-74 75-84 85-
U
s
e
 
P
r
o
b
a
b
i
l
i
t
y
E
x
p
e
n
d
i
t
u
r
e
 
(
1
,
0
0
0
 
J
P
Y
/
y
e
a
r
)
Age
Fi gure6.   I npati ent Servi ce Use  by Survi vorshi p and Age
Expendi ture 
per  user 
decedent
Expendi ture 
per  user 
survi vor
Use  probabi l i ty 
decedent
Use  probabi l i ty 
survi vor
 
Figure  7  shows  data  on  the  annual  use  of  institutional  care.  Two  observations  are  particularly 
notable here. First, the probability of use and monthly expenditure conditional on service use increased 
with age. Second, decedents had a higher probability of service use compared with survivors, but the 
monthly expenditure conditional on service use was similar between decedents and survivors. The 
trend in the use of homecare services was similar to the trend for institutional care.    
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Figure 7. Institutional care use by survivorship and age. 
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Figure 8 summarizes average annual expenditure by age, service type, and survivorship. Table 2 
presents  the  estimated  average annual  expenditure  by age,  sex,  service type,  and  survivorship. For 
decedents,  the  average  expenditure  on  medical  care  (outpatient  and  inpatient  services)  decreased 
sharply with age. However, this decline was offset by an increase in expenditure on LTC. As a result, 
there was only a moderate decrease in total healthcare cost with age. In contrast, the average total 
healthcare cost monotonously increased with age for survivors, primarily because of an increase in the 
cost of inpatient care and LTC.  
Figure 8. Average annual expenditure by service type, age and survivorship. 
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To compare our findings with those reported in The Netherlands [14] and the Switzerland [19], we 
conducted a similar analysis on the use pattern of outpatient and inpatient services stratified by the use 
of LTC. As mentioned earlier, the comparison should be interpreted with some caution because LTC in 
the Swiss study only included the medical component of LTC, while custodial care was included in the Int. J. Environ. Res. Public Health 2010, 7                 
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present report and the study in the Netherlands. In the Japanese context, people solely using medical 
care during the targeted 12 months may have experienced an acute onset of illness and health shock, 
while those who used both medical and LTC were more likely to suffer from a functional disability 
and  gradual  decline  in  their  health  status.  These  results  are  presented  in  Figures  9,  10,  and  11.  
We  found  that  the  probability  of  use  of  outpatient  service  was  the  highest  among  survivors  
without LTC use, followed by  decedents without LTC use, then by survivors and decedents with  
LTC use. Expenditure conditional on outpatient service use was higher for LTC users, and decreased 
over age (see Figure 9). 
Table  2.  Estimated  average  annual  expenditure  of  decedent  and  survivor  beneficiaries  
aged 65 and over. 
  Male    Female 
Age 65-74  Survivor  Decedent    Survivor  Decedent 
outpatient  439,493  626,356    403,907  566,967 
inpatient  307,130  2,802,176    224,355  2,644,243 
homecare  39,480  112,450    39,058  142,087 
institutional care  29,631  166,297    33,022  256,836 
Age 75–84           
outpatient  450,215  540,332      392,331  377,010 
inpatient  336,159  2,408,123    297,274  2,061,216 
homecare  53,913  173,560    94,900  212,864 
institutional care  43,266  315,442    107,735  611,494 
Age 85–            
outpatient  398,789  366,463      288,978  232,770 
inpatient  500,118  1,847,853    536,086  1,542,349 
homecare  151,674  301,256    224,418  287,824 
institutional care  164,352  667,081    463,933  1,209,633 
Unit; Japanese Yen (JPY; 100 JPY corresponds to approximately 1 USD) 
Figure 9. Outpatient service use by age, survivorship and LTC use. 
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As was the case for inpatient services (see Figure 10), the probability of use was more dependent on 
survivorship than LTC use. In fact, LTC use status did not seem to affect the probability of use among 
survivors. In the case of decedents, LTC users were less likely to use inpatient services as compared to 
LTC non-users. The pattern of annual expenditure conditional on service use for inpatient services 
appears  to  be  more  complicated.  Decedents  incurred  a  higher  annual  expenditure  than  survivors. 
Decedents with LTC use incurred the largest expenditure, and the amount varied only slightly across 
the different age categories. Decedents without LTC incurred the second largest annual expenditure 
conditional on service use, and this amount decreased sharply with age. For survivors, expenditure 
increased slightly with age among LTC users, and decreased slightly with age among LTC non-users.  
Figure 10. Inpatient service use by age, survivorship and LTC use. 
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However, as shown in Figure 11, annual average expenditure did not vary across age categories  
in the case of survivors, but decreased sharply across age categories in case of decedents, regardless  
of LTC use. 
Figure 11. Average medical service use by age, survivorship and LTC use. 
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Finally, we estimated the proportion of total health cost attributed to decedents, divided by age 
group. We found that the share was 0.100 for the 65–74 years age group, 0.124 for the 75–84 years age 
group, and 0.217 for the 85 plus age group. Medical care and LTC each had almost the same share in 
the total health cost of decedents across age groups.  
4. Discussion and Conclusions  
Surprisingly,  despite  differences  in  healthcare  systems  and  insurance  coverage  between  The 
Netherlands  and  Japan,  our  findings  are  relatively  similar  to  those  of  Polder,  et  al.  [14].  Elderly 
survivors were found to require less spending on medical care compared to decedents, and survivors‘ 
medical  costs  did  not  differ  across  age  categories.  Further,  since  LTC  increases  with  age  for  the 
surviving elderly, the total healthcare cost of survivors was found to be approximately half that of the 
decedents in  the  case of  people  aged  85  and over. Our findings  regarding the pattern of medical 
expenditure divided by LTC use status differ from those reported by Werblow, et al. [19]. Using Swiss 
data, they found that LTC non-use was related to larger annual expenditure among decedents. Our 
results, however, show the opposite. The Swiss case revealed that LTC users, both decedents and 
survivors, incurred less medical expenditure compared to LTC non-users. Again, our results do not 
show such an effect of LTC use status. This difference between the current findings and those based on 
the Swiss data is not surprising, since LTC services in the Swiss data correspond to medical services 
for chronic care in Japan. The Swiss data did not include custodial and chronic care provided in homes 
and institutions, whereas the Japanese and The Netherlands data included both medical and LTC, and 
therefore provide a more comprehensive measure of the ―total health cost‖ at the end of life. 
If we consider only medical expenditures, then TTD and survivorship clearly affect the amount of 
expenditure, and age per se is negatively associated with expenditure, potentially supporting the ―red 
herring‖ theory. However, our results, in accord with those from the Netherlands, suggest that although 
TTD  is  a  strong  predictor  of  higher  medical  expenditure  among  the  elderly,  and  age  per  se  is 
negatively correlated with medical expenditure among decedents,  LTC that increases with age for 
decedents and survivors does contribute to a higher total healthcare cost among the elderly.  
It could be argued, however, that an increase in the use of LTC with age might also be influenced 
by TTD, since the probability of death is higher for older people. Though this argument may have 
some validity, we cannot completely separate TTD from age in later life, because it is difficult to 
predict. In this study, the survivors had survived at least for 12 months. In spite of this, their total 
healthcare cost differed from that of their decedent counterparts in the same age category.  
These  findings  have  important  implications  for  medical  and  LTC  policy  in  Japan.  The  current 
results suggest that population aging results in increased demand and expenditure for LTC. Thus, 
substituting LTC for medical care at the end of life may not automatically lead to savings in resource 
use.  Another  implication  of  the  current  findings  is  that  contribution  of  aging  to  rising  healthcare 
expenditure should be distinguished according to survivorship. Total healthcare cost was found to be 
constant or to slightly decrease with age in decedents, suggesting that the cost until death is relatively 
stable among the elderly, while the risk of healthcare cost for survivors is proportional to age. This 
distinction should be taken into consideration in the design of insurance schemes, to appropriately 
cover healthcare costs among the elderly.  Int. J. Environ. Res. Public Health 2010, 7                 
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Some limitations of the current study should be taken into consideration. First, the data did not 
contain any relevant information regarding the quality of healthcare provided. Whether the quality of 
service in medical and LTC services differ across age and survivorship categories is an issue that 
requires further investigation. Moreover, the generalizability of our findings is limited because our data 
was derived from an insurer in a single prefecture. As such, larger-scale data collection from multiple 
insurers is necessary to confirm these results. In the statistical methodology we adopted, we could have 
used more sophisticated econometric estimation techniques to determine the probability and amount of 
service use, including regression models. We chose not to do so because our dataset contained only 
age and sex as potential regressor variables. More detailed data on the characteristics of beneficiaries, 
especially on health status and detailed diagnoses would be helpful to further clarify the pattern of 
healthcare resource use in later life. 
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